2a97: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:2a97.png|left|200px]] | [[Image:2a97.png|left|200px]] | ||
{{STRUCTURE_2a97| PDB=2a97 | SCENE= }} | {{STRUCTURE_2a97| PDB=2a97 | SCENE= }} | ||
===Crystal structure of catalytic domain of Clostridium botulinum neurotoxin serotype F=== | ===Crystal structure of catalytic domain of Clostridium botulinum neurotoxin serotype F=== | ||
{{ABSTRACT_PUBMED_16128577}} | {{ABSTRACT_PUBMED_16128577}} | ||
==About this Structure== | ==About this Structure== | ||
[[2a97]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Clostridium_botulinum Clostridium botulinum]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2A97 OCA]. | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:016128577</ref><references group="xtra"/> | ||
[[Category: Bontoxilysin]] | [[Category: Bontoxilysin]] | ||
[[Category: Clostridium botulinum]] | [[Category: Clostridium botulinum]] | ||
| Line 32: | Line 20: | ||
[[Category: Clostridium botulinum neurotoxin serotype f]] | [[Category: Clostridium botulinum neurotoxin serotype f]] | ||
[[Category: Crystal structure]] | [[Category: Crystal structure]] | ||
[[Category: Hydrolase]] | |||
[[Category: Light chain]] | [[Category: Light chain]] | ||
[[Category: X-ray]] | [[Category: X-ray]] | ||
[[Category: Zinc endopeptidase]] | [[Category: Zinc endopeptidase]] | ||
Revision as of 15:12, 6 January 2013
Crystal structure of catalytic domain of Clostridium botulinum neurotoxin serotype FCrystal structure of catalytic domain of Clostridium botulinum neurotoxin serotype F
Template:ABSTRACT PUBMED 16128577
About this StructureAbout this Structure
2a97 is a 2 chain structure with sequence from Clostridium botulinum. Full crystallographic information is available from OCA.
ReferenceReference
- ↑ Agarwal R, Binz T, Swaminathan S. Structural analysis of botulinum neurotoxin serotype F light chain: implications on substrate binding and inhibitor design. Biochemistry. 2005 Sep 6;44(35):11758-65. PMID:16128577 doi:10.1021/bi0510072